Prescient gets FDA breakthrough status for colorectal cancer test

by | Sep 6, 2019 | FDA

Prescient Metabiomics has received FDA breakthrough status for its non-invasive colorectal cancer test. The test, called LifeKit Prevent, identifies microbial DNA and RNA biomarkers associated with the new, abnormal growth of tissue in the gastrointestinal tract. By...